| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2015 | US8969077 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 03/03/2015 | US8968811 Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
| 03/03/2015 | US8968801 Supplement composition for supporting DNA repair and method of use |
| 03/03/2015 | US8968799 Time delayed release mechanism for energizing composition and method of use |
| 03/03/2015 | US8968796 Ingestible canker sore treatment |
| 03/03/2015 | US8968794 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968793 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968792 Pharmaceutical combination for the treatment of renal failure in pets |
| 03/03/2015 | US8968784 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery |
| 03/03/2015 | US8968783 Hydrogel implants with varying degrees of crosslinking |
| 03/03/2015 | US8968781 Therapeutic compositions |
| 03/03/2015 | US8968780 Stabilized pharmaceutical composition |
| 03/03/2015 | US8968779 Controlled release coat-core tablet |
| 03/03/2015 | US8968778 Threo-DOPS controlled release formulation |
| 03/03/2015 | US8968777 Tranexamic acid formulations with reduced adverse effects |
| 03/03/2015 | US8968776 Composition comprising a benzimidazole and process for its manufacture |
| 03/03/2015 | US8968775 Microemulsion topical delivery platform |
| 03/03/2015 | US8968774 Preparation and composition of meloxicam transdermal drug delivery system |
| 03/03/2015 | US8968770 Multi-part kit comprising a chewing gum and further a flavor containing formulation |
| 03/03/2015 | US8968768 Phytosterol nutritional supplements |
| 03/03/2015 | US8968767 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 03/03/2015 | US8968763 Block biodegradable copolymers for medical devices |
| 03/03/2015 | US8968759 Method of administering an injectable antibiotic to an animal |
| 03/03/2015 | US8968755 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 03/03/2015 | US8968753 Ceftolozane-tazobactam pharmaceutical compositions |
| 03/03/2015 | US8968751 Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology |
| 03/03/2015 | US8968735 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 03/03/2015 | US8968733 Functionalized surgical adhesives |
| 03/03/2015 | US8968731 Treatment of uveitis |
| 03/03/2015 | US8968726 Lactoferrin and angiogenin compositions and uses thereof |
| 03/03/2015 | US8968722 Milk-based nutritional compositions containing lactoferrin and uses thereof |
| 03/03/2015 | US8968716 In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| 03/03/2015 | US8968715 Drug delivery systems for photodynamic therapy |
| 03/03/2015 | US8968714 Carrier nanoparticles and related compositions, methods and systems |
| 03/03/2015 | US8968710 Topical anesthetic |
| 03/03/2015 | US8968708 Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| 03/03/2015 | US8968706 Methods for diagnosing and treating loss or distortion of taste |
| 03/03/2015 | US8968705 Gold/lanthanide nanoparticle conjugates and uses thereof |
| 03/03/2015 | US8968234 Method of using vasoconstrictive agents during energy-based tissue therapy |
| 02/28/2015 | CA2825821A1 1-phenylalkanecarboxylic acid derivatives for the treatment of alzheimer's disease and multiple sclerosis |
| 02/26/2015 | WO2015027227A1 Neuroactive steroids, compositions, and uses thereof |
| 02/26/2015 | WO2015027222A2 Certain chemical entities, compositions, and methods |
| 02/26/2015 | WO2015027214A1 Substituted thieno[2,3-c]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| 02/26/2015 | WO2015027212A1 Diaminopyrimidine p2x3 and p2x 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough |
| 02/26/2015 | WO2015027206A1 Methods of treating and preventing endothelial dysfunction using bardoxololone methyl or analogs thereof |
| 02/26/2015 | WO2015027204A1 Substituted thieno[2,3-b]pyridine-2-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| 02/26/2015 | WO2015027201A1 Methods and compositions for enhancing female sexual wellness |
| 02/26/2015 | WO2015027176A1 Water soluble fluorescent or colored dyes and methods for their use |
| 02/26/2015 | WO2015027160A2 Allosteric modulators of the cannibinoid 1 receptor |
| 02/26/2015 | WO2015027146A1 Inhibitors of human 12/15-lipoxygenase |
| 02/26/2015 | WO2015027137A1 Improved synthesis of capuramycin and its analogues |
| 02/26/2015 | WO2015027125A1 Multiple myeloma treatment |
| 02/26/2015 | WO2015027124A1 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
| 02/26/2015 | WO2015027111A1 Compositions, methods and systems for the treatment of cutaneous disorders |
| 02/26/2015 | WO2015027071A1 Gpr81 agonists and methods thereof for promoting production of secretory iga |
| 02/26/2015 | WO2015027040A2 Methods and compositions for treating schistosome infection |
| 02/26/2015 | WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015027015A1 Imidazole-derived modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015026963A2 Phthalocy anine-dendrimer compositions and a method of using |
| 02/26/2015 | WO2015026935A2 Hdac8 inhibitors for treating cancer |
| 02/26/2015 | WO2015026934A1 Bruton's tyrosine kinase as anti-cancer drug target |
| 02/26/2015 | WO2015026922A1 Alkyl derivatives as sphingosine-1 phosphate receptors modulators |
| 02/26/2015 | WO2015026914A1 Azetidine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/26/2015 | WO2015026852A1 Method of inducing an anti-retroviral immune response by counter-acting retro-virus induced anti-apoptosis |
| 02/26/2015 | WO2015026849A1 Compounds and methods for treating an epileptic disorder |
| 02/26/2015 | WO2015026818A1 Survival benefit in patients with solid tumors with elevated c-reactive protein levels |
| 02/26/2015 | WO2015026796A1 Heterocycle analogs of cai-1 as agonists of quorum sensing in vibrio |
| 02/26/2015 | WO2015026792A1 Antiviral compounds |
| 02/26/2015 | WO2015026761A1 A process for the preparation of rivaroxaban |
| 02/26/2015 | WO2015026708A2 Amelioration of the effects of friedriech's ataxia |
| 02/26/2015 | WO2015026693A1 7a-amide substituted-6,6-difluoro bicyclic himbacine derivatives |
| 02/26/2015 | WO2015026686A1 3'-pyridyl substituted- 6,6-difluoro bicyclic himbacine derivatives |
| 02/26/2015 | WO2015026685A1 7a-heterocycle substituted- 6, 6-difluoro bicyclic himbacine derivatives |
| 02/26/2015 | WO2015026683A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity |
| 02/26/2015 | WO2015026611A1 Micro-rna regulation of bone loss |
| 02/26/2015 | WO2015026601A2 Dithiol mucolytic agents |
| 02/26/2015 | WO2015026574A1 Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia |
| 02/26/2015 | WO2015026484A1 Antibody-mediated anti-tumor activity induced by reishi mushroom polysaccharides |
| 02/26/2015 | WO2015026454A1 Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis c virus |
| 02/26/2015 | WO2015026380A1 Composition for treating ocular effects of diabetes |
| 02/26/2015 | WO2015026339A1 Composition for reducing nervous system injury and method of making and use thereof |
| 02/26/2015 | WO2015026249A1 Use of a mir172 molecule for decreasing inflammation |
| 02/26/2015 | WO2015026215A1 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient |
| 02/26/2015 | WO2015026205A1 Composition for preventing and treating immune diseases, containing daurinol compound as active ingredient |
| 02/26/2015 | WO2015026172A1 Indole amide compound as inhibitor of necrosis |
| 02/26/2015 | WO2015026170A1 Indole compound as inhibitor of necrosis |
| 02/26/2015 | WO2015026124A1 Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma |
| 02/26/2015 | WO2015026123A1 Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating chronic obstructive pulmonary diseases |
| 02/26/2015 | WO2015026114A1 Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating rheumatoid arthritis |
| 02/26/2015 | WO2015026112A1 Composition containing monoacetyldiglyceride compound as active ingredient for inhibiting blood cancer or metastasis |
| 02/26/2015 | WO2015025980A1 Method for treating neuropathic pain |
| 02/26/2015 | WO2015025962A1 Amidine compound or salt thereof |
| 02/26/2015 | WO2015025936A1 Novel quinoline-substituted compound |
| 02/26/2015 | WO2015025914A1 Salt of indole derivatives and crystal thereof |
| 02/26/2015 | WO2015025871A1 Methods for evaluating and screening s1p1 receptor agonists |
| 02/26/2015 | WO2015025816A1 Chymase inhibitor and medicine comprising chymase inhibitor |
| 02/26/2015 | WO2015025815A1 Polyrotaxane and medicinal composition |
| 02/26/2015 | WO2015025767A1 Transdermal patch |
| 02/26/2015 | WO2015025766A1 Transdermal patch |
| 02/26/2015 | WO2015025718A1 Adhesive patch |